BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30273693)

  • 1. PAC1 regulates receptor tyrosine kinase transactivation in a reactive oxygen species-dependent manner.
    Moody TW; Lee L; Iordanskaia T; Ramos-Alvarez I; Moreno P; Boudreau HE; Leto TL; Jensen RT
    Peptides; 2019 Oct; 120():170017. PubMed ID: 30273693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G Protein-Coupled Receptor PAC1 Regulates Transactivation of the Receptor Tyrosine Kinase HER3.
    Moody TW; Lee L; Jensen RT
    J Mol Neurosci; 2021 Aug; 71(8):1589-1597. PubMed ID: 32964398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells.
    Moody TW; Osefo N; Nuche-Berenguer B; Ridnour L; Wink D; Jensen RT
    J Pharmacol Exp Ther; 2012 Jun; 341(3):873-81. PubMed ID: 22389426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.
    Moody TW; Ramos-Alvarez I; Moreno P; Mantey SA; Ridnour L; Wink D; Jensen RT
    Peptides; 2017 Apr; 90():90-99. PubMed ID: 28153500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin receptors regulate transactivation of the EGFR and HER2 in a reactive oxygen species-dependent manner.
    Moody TW; Lee L; Ramos-Alvarez I; Jensen RT
    Eur J Pharmacol; 2019 Dec; 865():172735. PubMed ID: 31614143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PYK-2 is tyrosine phosphorylated after activation of pituitary adenylate cyclase activating polypeptide receptors in lung cancer cells.
    Moody TW; Di Florio A; Jensen RT
    J Mol Neurosci; 2012 Nov; 48(3):660-6. PubMed ID: 22581436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancer.
    Watanabe S; Hayashi H; Haratani K; Shimizu S; Tanizaki J; Sakai K; Kawakami H; Yonesaka K; Tsurutani J; Togashi Y; Nishio K; Ito A; Nakagawa K
    Cancer Sci; 2019 Jan; 110(1):52-60. PubMed ID: 30390416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells.
    Moody TW; Berna MJ; Mantey S; Sancho V; Ridnour L; Wink DA; Chan D; Giaccone G; Jensen RT
    Eur J Pharmacol; 2010 Jul; 637(1-3):38-45. PubMed ID: 20388507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation.
    Leung EL; Fan XX; Wong MP; Jiang ZH; Liu ZQ; Yao XJ; Lu LL; Zhou YL; Yau LF; Tin VP; Liu L
    Antioxid Redox Signal; 2016 Feb; 24(5):263-79. PubMed ID: 26528827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway.
    Leone A; Roca MS; Ciardiello C; Terranova-Barberio M; Vitagliano C; Ciliberto G; Mancini R; Di Gennaro E; Bruzzese F; Budillon A
    Free Radic Biol Med; 2015 Dec; 89():287-99. PubMed ID: 26409771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Licochalcone B inhibits growth and induces apoptosis of human non-small-cell lung cancer cells by dual targeting of EGFR and MET.
    Oh HN; Lee MH; Kim E; Yoon G; Chae JI; Shim JH
    Phytomedicine; 2019 Oct; 63():153014. PubMed ID: 31323446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
    Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
    Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling pathways activated by PACAP in MCF-7 breast cancer cells.
    Zibara K; Zeidan A; Mallah K; Kassem N; Awad A; Mazurier F; Badran B; El-Zein N
    Cell Signal; 2018 Oct; 50():37-47. PubMed ID: 29935235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment.
    Kawano Y; Iwama E; Tsuchihashi K; Shibahara D; Harada T; Tanaka K; Nagano O; Saya H; Nakanishi Y; Okamoto I
    Lung Cancer; 2017 Nov; 113():72-78. PubMed ID: 29110853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NADPH oxidase 4 induces apoptosis in malignant mesothelioma: Role of reactive oxygen species.
    Tanaka M; Miura Y; Numanami H; Karnan S; Ota A; Konishi H; Hosokawa Y; Hanyuda M
    Oncol Rep; 2015 Oct; 34(4):1726-32. PubMed ID: 26238284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide causes increased tyrosine phosphorylation of focal adhesion kinase and paxillin.
    Moody TW; Leyton J; Jensen RT
    J Mol Neurosci; 2012 Jan; 46(1):68-74. PubMed ID: 21898124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC).
    Codony-Servat C; Codony-Servat J; Karachaliou N; Molina MA; Chaib I; Ramirez JL; de Los Llanos Gil M; Solca F; Bivona TG; Rosell R
    Oncotarget; 2017 Jul; 8(29):47305-47316. PubMed ID: 28521301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
    Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
    Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
    Zhou YL; Xu YJ; Qiao CW
    Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src family kinase inhibitors blunt PACAP-induced PAC1 receptor endocytosis, phosphorylation of ERK, and the increase in cardiac neuron excitability.
    Tompkins JD; Clason TA; Buttolph TR; Girard BM; Linden AK; Hardwick JC; Merriam LA; May V; Parsons RL
    Am J Physiol Cell Physiol; 2018 Feb; 314(2):C233-C241. PubMed ID: 29141923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.